SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM)所有资讯

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

04/16 05:20

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 10-K：年度报表

03/30 01:23

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

03/29 21:37

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

03/09 05:31

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | S-8：员工福利计划证券登记

02/24 11:18

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4：持股变动声明-高管 Bausch Christoph Lawrence

02/24 11:16

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4：持股变动声明-高管 Kropotova Alexandra

02/24 06:06

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4：持股变动声明-高管 Sullivan Eddie Joe

02/24 06:05

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4：持股变动声明-高管 King Michael

02/24 05:57

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4：持股变动声明-高管 Reich Samuel J

02/24 05:46

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)

02/15 07:07

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G：超过5%持股股东披露文件-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)

02/14 20:06

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A：超过5%持股股东披露文件(修正)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%)等

02/14 19:32

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

02/02 20:55

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

01/27 05:22

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 424B5：募资说明书

01/27 05:05

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

01/26 06:08

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

01/19 13:00

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 8-K：重大事件

01/03 13:00

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | DEF 14A：股东委托书决议

2023/12/18 22:34